(00:32)
 Could you provide a little bit of background about yourself?

(01:43)
 Could you give a brief overview of the new melanoma assay?

(04:53)
 Is the assay able to provide diagnostic, prognostic and classification information, and potential therapeutic implications?

(05:12)
 Could you talk a little more about the MSI assessment in this panel? 

(05:59)
 Which patients should have this testing?

(07:01)
 How are these results used in patient care?

(08:39)
 Is there anything else you'd like to add?